Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3868-3873

  Lee, Nahyoung G ^a,b   Berry, Jesse L ^a,b   Lee, Tom C ^a,c   Wang, Annie T ^a   Honowitz, Scott ^a   Linn Murphree, A ^a,c   Varshney, Neeta ^a   Hinton, David R ^a,b   Fawzi, Amani A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC;

ARTICLE; CANCER CHEMOTHERAPY; CELL COUNT; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBUBBLE; NUCLEAR PORE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINOBLASTOMA; SCANNING ELECTRON MICROSCOPY; ULTRASOUND; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG POTENTIATION; ECHOGRAPHY; RETINA TUMOR; TUMOR CELL CULTURE; ULTRASTRUCTURE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL COUNT; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; HUMANS; MICROBUBBLES; MICROSCOPY, ELECTRON, SCANNING; RETINAL NEOPLASMS; RETINAL PIGMENT EPITHELIUM; RETINOBLASTOMA; SONICATION; TUMOR CELLS, CULTURED;

EID: 80051731829     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6501     Document Type: Article

References (38)

1. Boubacar T, Fatou S, Fousseyni T, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol. 2010;94:467-469.
2. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21:203-212.
3. MacPherson D, Dyer MA. Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy. Cancer Res. 2007;67:7547-7550.
4. Lin P, O'Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol. 2009;148:192-198.
5. Chan HS, Gallie BL, Munier FL, Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18:55-63, viii.
6. Abramson DH. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture. Br J Ophthalmol. 2010;94:396-399.
7. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398-1404.
8. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623-1629.
9. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010;128: 370-372.
10. Abramson DH. Periocular chemotherapy for retinoblastoma: success with problems? Arch Ophthalmol. 2005;123:128-129, author reply 129.
11. Pontes de Carvalho RA, Krausse ML, Murphree AL, Schmitt EE, Campochiaro PA, Maumenee IH. Delivery from episcleral exoplants. Invest Ophthalmol Vis Sci. 2006;47:4532-4539.
12. Kim SH, Lutz RJ, Wang NS, Robinson MR. Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res. 2007;39:244-254.
13. Casey G, Cashman JP, Morrissey D, et al. Sonoporation-mediated immunogene therapy of solid tumors. Ultrasound Med Biol. 2010; 36:430-440.
14. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009;54:R27-R57.
15. van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006;112:149-155.
16. Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci. 2007;12:5124-5142.
17. Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol. 1996;22:1131-1154.
18. Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther. 18:101-108.
19. Nelson JL, Roeder BL, Carmen JC, Roloff F, Pitt WG. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res. 2002;62:7280-7283.
20. Sonoda S, Tachibana K, Uchino E, et al. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther. 2007;6:1276-1283.
21. Hirokawa T, Karshafian R, Pavlin CJ, Burns PN. Insonation of the eye in the presence of microbubbles: preliminary study of the duration and degree of vascular bioeffects-work in progress. J Ultrasound Med. 2007;26:731-738.
22. Rizzuti AE, Dunkel IJ, Abramson DH. The adverse events of chemotherapy for retinoblastoma: what are they? Do we know? Arch Ophthalmol. 2008;126:862-865.
23. Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, Hinton DR. A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc. 2009;4:662-673.
24. Hamilton N. Quantification and its applications in fluorescent microscopy imaging. Traffic. 2009;10:951-961.
25. Yoshida T, Kondo T, Ogawa R, et al. Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother Pharmacol. 2008;61:559-567.
26. Liu Y, Liu Z, Li T, Ye G. Ultrasonic sonoporation can enhance the prostate permeability. Med Hypotheses. 2010;74:449-451.
27. Iwanaga K, Tominaga K, Yamamoto K, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther. 2007;14:354-363.
28. Maeda H, Tominaga K, Iwanaga K, et al. Targeted drug delivery system for oral cancer therapy using sonoporation. J Oral Pathol Med. 2009;38:572-579.
29. Liang HD, Tang J, Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H. 2010;224:343-361.
30. Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol. 2004;30:519-526.
31. Zhou Y, Shi J, Cui J, Deng CX. Effects of extracellular calcium on cell membrane resealing in sonoporation. J Control Release. 2008; 126:34-43.
32. Meijering BD, Juffermans LJ, van Wamel A, et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res. 2009;104: 679-687.
33. Zhou Y, Kumon RE, Cui J, Deng CX. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol. 2009;35: 1756-1760.
34. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol. 2006;32:915-924.
35. Zhao YZ, Luo YK, Lu CT, et al. Phospholipids-based microbubbles sonoporation pore size and reseal of cell membrane cultured in vitro. J Drug Target. 2008;16:18-25.
36. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release. 2005;104:213-222.
37. Feril LB Jr, Kondo T. Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound. J Radiat Res (Tokyo). 2004;45:479-489.
38. Fine IH, Packer M, Hoffman RS. New phacoemulsification technologies. J Cataract Refract Surg. 2002;28:1054-1060.